Iovance Biotherapeutics Inc (IOVA)
13.42
+0.54
(+4.19%)
USD |
NASDAQ |
May 03, 14:01
Iovance Biotherapeutics 1 Year Total Returns (Daily): 110.1% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 110.1% |
| May 01, 2024 | 94.40% |
| April 30, 2024 | 108.9% |
| April 29, 2024 | 113.3% |
| April 26, 2024 | 112.8% |
| April 25, 2024 | 109.4% |
| April 24, 2024 | 105.4% |
| April 23, 2024 | 107.7% |
| April 22, 2024 | 98.25% |
| April 19, 2024 | 93.33% |
| April 18, 2024 | 106.3% |
| April 17, 2024 | 103.1% |
| April 16, 2024 | 111.3% |
| April 15, 2024 | 110.8% |
| April 12, 2024 | 129.7% |
| April 11, 2024 | 139.8% |
| April 10, 2024 | 125.4% |
| April 09, 2024 | 122.9% |
| April 08, 2024 | 120.4% |
| April 05, 2024 | 130.5% |
| April 04, 2024 | 129.7% |
| April 03, 2024 | 123.1% |
| April 02, 2024 | 125.4% |
| April 01, 2024 | 132.2% |
| March 28, 2024 | 138.6% |
| Date | Value |
|---|---|
| March 27, 2024 | 129.3% |
| March 26, 2024 | 154.1% |
| March 25, 2024 | 162.7% |
| March 22, 2024 | 153.3% |
| March 21, 2024 | 144.2% |
| March 20, 2024 | 135.9% |
| March 19, 2024 | 115.2% |
| March 18, 2024 | 117.2% |
| March 15, 2024 | 104.0% |
| March 14, 2024 | 113.7% |
| March 13, 2024 | 126.6% |
| March 12, 2024 | 137.0% |
| March 11, 2024 | 143.2% |
| March 08, 2024 | 126.2% |
| March 07, 2024 | 130.8% |
| March 06, 2024 | 147.3% |
| March 05, 2024 | 124.4% |
| March 04, 2024 | 130.7% |
| March 01, 2024 | 130.0% |
| February 29, 2024 | 118.2% |
| February 28, 2024 | 139.1% |
| February 27, 2024 | 143.7% |
| February 26, 2024 | 137.1% |
| February 23, 2024 | 117.5% |
| February 22, 2024 | 115.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-72.14%
Minimum
Jan 19 2022
284.3%
Maximum
Dec 23 2019
16.96%
Average
-13.17%
Median
Oct 12 2021
1 Year Total Returns (Daily) Benchmarks
| QuidelOrtho Corp | -53.87% |
| Perspective Therapeutics Inc | 179.0% |
| Electromed Inc | 70.76% |
| Xtant Medical Holdings Inc | 32.40% |
| Asensus Surgical Inc | -60.48% |